BMO Capital Maintains Market Perform on Genpact, Lowers Price Target to $41
Portfolio Pulse from richadhand@benzinga.com
BMO Capital analyst Keith Bachman has maintained a 'Market Perform' rating on Genpact (NYSE:G) but lowered the price target from $46 to $41.
August 10, 2023 | 1:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Genpact's price target has been lowered from $46 to $41 by BMO Capital, though the 'Market Perform' rating is maintained.
The lowering of the price target by BMO Capital indicates a potential decrease in Genpact's stock price in the short term. However, the maintenance of the 'Market Perform' rating suggests that the company's overall performance is expected to be in line with the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100